Disclosures

Dr. Brugarolas is a consultant for Prometheus Laboratories (Nestlé Health Science) and the chair of the scientific advisory board for Bethyl laboratories. He has received research funding from Novartis and Peloton Therapeutics, and has an ongoing collaboration with Genentech.